Anton Xavier MSc, MBA
Prior to SVB, Anton worked at the NY State Center for Biotechnology focusing on the development and implementation of technology and business development strategies to increase sponsored research, company formation, strategic alliances and investment with external partners.
Prior to that Anton was with Pfizer where he had duties within the External Science and Innovation group (ES&I) focusing on sourcing, screening and evaluating early through to late stage (inter)national biopharma ventures, entrepreneurial academic PI technology, private/public/local government funded life science initiatives as well as funding vehicles which aligned with Pfizer’s R&D interest for investment and strategic partnerships. Additionally, Anton led efforts within Pfizer R&D from discovery through to late stage development of targeted therapeutics for oncology indications.
Anton’s academic experience has impacted a wide field of bioscience including: regenerative medicine, infectious disease and cardiovascular biology where he developed multiple therapeutic, platform and diagnostic innovations for military and industrial needs.
Anton earned a Master’s degree in Business Administration (MBA) from Cornell University’s Johnson Graduate School of Management, a Master of Science (MSc) in Toxicology from Imperial College London and a dual major Bachelor of Science (BSc) in Biochemistry with Microbiology from Queen Mary and Westfield University of London.